NAV
$32.63
AUM
$2.3B
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.69
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +5.45% | +1.59% | -0.05% | +13.83% | +17.02% | +11.09% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ROP.SW | Roche Holding AG Ordinary Shares new | 5.02% |
| 2 | NESN.SW | Nestle SA | 4.99% |
| 3 | NOVN.SW | Novartis AG Registered Shares | 4.97% |
| 4 | SHEL.L | Shell PLC | 4.75% |
| 5 | TTE.PA | TotalEnergies SE | 4.21% |
| 6 | ALV.DE | Allianz SE | 4.13% |
| 7 | NOVO-B.CO | Novo Nordisk AS Class B | 3.59% |
| 8 | IBE.MC | Iberdrola SA | 3.37% |
| 9 | BATS.L | British American Tobacco PLC | 3.03% |
| 10 | ULVR.L | Unilever PLC | 3.02% |
The fund will invest at least 80% of its total assets (but typically far more) in component securities of the underlying index. The underlying index is designed to reflect the performance of equities in its parent index, the MSCI EAFE Index, with higher dividend income and quality characteristics than average dividend yields of equities in the parent index, where such higher dividend income and quality characteristics are both sustainable and persistent. It is non-diversified.
Inception Date: 2015-08-12